ADC Historical Cash Flow
| ADCT Stock | USD 2.03 0.04 2.01% |
Analysis of ADC Therapeutics cash flow over time is an excellent tool to project ADC Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 25.7 M or Change In Working Capital of 46.5 M as it is a great indicator of ADC Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining ADC Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether ADC Therapeutics is a good buy for the upcoming year.
ADC |
About ADC Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in ADC balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which ADC's non-liquid assets can be easily converted into cash.
ADC Therapeutics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of ADC Therapeutics value has been used up. For tax purposes ADC Therapeutics can deduct the cost of the tangible assets it purchases as business expenses. However, ADC Therapeutics SA must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Capital Expenditures
Capital Expenditures are funds used by ADC Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of ADC Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from ADC Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into ADC Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADC Therapeutics SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, ADC Therapeutics' End Period Cash Flow is comparatively stable compared to the past year. Change To Netincome is likely to gain to about 60 M in 2024, despite the fact that Change In Cash is likely to grow to (45.5 M).
ADC Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
ADC Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ADC Therapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (24K) | (141K) | 0.0 | (221K) | (198.9K) | (189.0K) | |
| Change To Inventory | 1.6M | (2.3M) | (3.0M) | (9.0M) | 1.6M | 1.7M | |
| Investments | (2.2M) | (2.8M) | (6.7M) | (2.5M) | (2.4M) | (2.5M) | |
| Change In Cash | (23.3M) | 323.6M | 27.3M | (140.1M) | (47.8M) | (45.5M) | |
| Stock Based Compensation | 1.1M | 37.6M | 60.5M | 49.3M | 13.5M | 25.7M | |
| Free Cash Flow | (123.7M) | (171.5M) | (239.8M) | (139.1M) | (121.9M) | (128.0M) | |
| Change In Working Capital | (7.9M) | 12.4M | (20.3M) | (33.0M) | 44.3M | 46.5M | |
| Begin Period Cash Flow | 138.8M | 115.6M | 439.2M | 466.5M | 326.4M | 297.5M | |
| Total Cashflows From Investing Activities | (2.2M) | (2.8M) | (6.7M) | (2.5M) | (2.3M) | (2.4M) | |
| Other Cashflows From Financing Activities | 101.6M | 54K | 218.8M | (4.3M) | 73.9M | 60.4M | |
| Depreciation | 1.6M | 2.2M | 2.6M | 2.3M | 3.3M | 2.1M | |
| Other Non Cash Items | (1.2M) | 25.1M | (24.7M) | 1.1M | 23.2M | 24.4M | |
| Capital Expenditures | 2.1M | 2.8M | 6.4M | 2.3M | 3.2M | 3.5M | |
| Total Cash From Operating Activities | (121.6M) | (168.7M) | (233.4M) | (136.8M) | (118.7M) | (124.6M) | |
| Change To Account Receivables | 895K | 192K | (30.2M) | (42.8M) | 47.8M | 50.2M | |
| Change To Operating Activities | (2.1M) | 10.4M | 6.2M | 16.5M | 19.0M | 20.0M | |
| Net Income | (116.5M) | (246.3M) | (230.0M) | (155.8M) | (240.1M) | (252.1M) | |
| Total Cash From Financing Activities | 100.5M | 495.0M | 267.4M | (593K) | 73.9M | 129.5M | |
| End Period Cash Flow | 115.6M | 439.2M | 466.5M | 326.4M | 278.6M | 318.7M | |
| Other Cashflows From Investing Activities | (100K) | (19K) | (297K) | (210K) | (189K) | (198.5K) | |
| Change To Netincome | 951K | 63.2M | 14.3M | 49.7M | 57.1M | 60.0M | |
| Change To Liabilities | (5.8M) | 1.9M | 6.8M | 310K | 356.5K | 338.7K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ADC Stock Analysis
When running ADC Therapeutics' price analysis, check to measure ADC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADC Therapeutics is operating at the current time. Most of ADC Therapeutics' value examination focuses on studying past and present price action to predict the probability of ADC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADC Therapeutics' price. Additionally, you may evaluate how the addition of ADC Therapeutics to your portfolios can decrease your overall portfolio volatility.